Rapid and Effective Neuronal Conversion of Human Glioblastoma In Vitro and In Vivo Using Potent Small Molecules

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Ya'nan Hu, Jinming Liu, Jian Tu, Min Yang, Qisheng He, Fei Li, Xiaojing Xu, Zhongqing Ji, Jianwei Xu, Wentao Zhong, Mengwen Yan, Ying Yang, Huanxiang Zhang
Natura: Artículo Open Access
Pubblicazione: Wiley 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867005421269549057
author Ya'nan Hu
Jinming Liu
Jian Tu
Min Yang
Qisheng He
Fei Li
Xiaojing Xu
Zhongqing Ji
Jianwei Xu
Wentao Zhong
Mengwen Yan
Ying Yang
Huanxiang Zhang
author_facet Ya'nan Hu
Jinming Liu
Jian Tu
Min Yang
Qisheng He
Fei Li
Xiaojing Xu
Zhongqing Ji
Jianwei Xu
Wentao Zhong
Mengwen Yan
Ying Yang
Huanxiang Zhang
Ya'nan Hu
Jinming Liu
Jian Tu
Min Yang
Qisheng He
Fei Li
Xiaojing Xu
Zhongqing Ji
Jianwei Xu
Wentao Zhong
Mengwen Yan
Ying Yang
Huanxiang Zhang
collection Wiley Open Access
contents Rapid and Effective Neuronal Conversion of Human Glioblastoma In Vitro and In Vivo Using Potent Small Molecules Ya'nan Hu Jinming Liu Jian Tu Min Yang Qisheng He Fei Li Xiaojing Xu Zhongqing Ji Jianwei Xu Wentao Zhong Mengwen Yan Ying Yang Huanxiang Zhang Cell Proliferation ABSTRACTExploring effective, prompt and universally applicable approaches for inducing the differentiation of glioblastoma (GBM) into terminally differentiated cells, such as astrocytes or neurons that cease cell division, is pivotal for the success of GBM differentiation therapy. In this study, a neuronal‐specific promoter–reporter system was employed to screen small molecules that promote neural differentiation. The cocktail YFSS, consisting of Y27632, Forskolin, SB431542 and SP600125, which selectively targets the ROCK, cAMP, TGF‐β and JNK signalling pathways, respectively, was found to effectively trigger differentiation in human GBM cells. This process yielded neuron‐like cells within 7 days, inhibited GBM cell proliferation and reduced malignancy traits, such as stemness, migratory and invasive capabilities. Transcriptome sequencing revealed the pathways altered by YFSS, shedding light on its dual role in halting cell proliferation and initiating neuronal differentiation. A notable increase in CEND1 expression, a key molecule in cell cycle and neuronal differentiation regulation, was observed during differentiation. However, CEND1 alone could not replicate YFSS's high conversion efficiency and its depletion reduced the differentiation and restored proliferation of the GBM cells. In vivo, prolonged and localised YFSS application significantly curtailed tumour growth and extended survival in patient‐derived xenograft mice models. In summary, our findings reveal that the small‐molecule cocktail YFSS is an effective means for inducing neuronal differentiation in GBM cells, representing a novel and promising pathway for the advancement of GBM treatment. 10.1111/cpr.70013 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/cpr.70013
format Artículo Open Access
id wiley_oa_10_1111_cpr_70013
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Rapid and Effective Neuronal Conversion of Human Glioblastoma In Vitro and In Vivo Using Potent Small Molecules
Ya'nan Hu
Jinming Liu
Jian Tu
Min Yang
Qisheng He
Fei Li
Xiaojing Xu
Zhongqing Ji
Jianwei Xu
Wentao Zhong
Mengwen Yan
Ying Yang
Huanxiang Zhang
Cell Proliferation
Rapid and Effective Neuronal Conversion of Human Glioblastoma In Vitro and In Vivo Using Potent Small Molecules Ya'nan Hu Jinming Liu Jian Tu Min Yang Qisheng He Fei Li Xiaojing Xu Zhongqing Ji Jianwei Xu Wentao Zhong Mengwen Yan Ying Yang Huanxiang Zhang Cell Proliferation ABSTRACTExploring effective, prompt and universally applicable approaches for inducing the differentiation of glioblastoma (GBM) into terminally differentiated cells, such as astrocytes or neurons that cease cell division, is pivotal for the success of GBM differentiation therapy. In this study, a neuronal‐specific promoter–reporter system was employed to screen small molecules that promote neural differentiation. The cocktail YFSS, consisting of Y27632, Forskolin, SB431542 and SP600125, which selectively targets the ROCK, cAMP, TGF‐β and JNK signalling pathways, respectively, was found to effectively trigger differentiation in human GBM cells. This process yielded neuron‐like cells within 7 days, inhibited GBM cell proliferation and reduced malignancy traits, such as stemness, migratory and invasive capabilities. Transcriptome sequencing revealed the pathways altered by YFSS, shedding light on its dual role in halting cell proliferation and initiating neuronal differentiation. A notable increase in CEND1 expression, a key molecule in cell cycle and neuronal differentiation regulation, was observed during differentiation. However, CEND1 alone could not replicate YFSS's high conversion efficiency and its depletion reduced the differentiation and restored proliferation of the GBM cells. In vivo, prolonged and localised YFSS application significantly curtailed tumour growth and extended survival in patient‐derived xenograft mice models. In summary, our findings reveal that the small‐molecule cocktail YFSS is an effective means for inducing neuronal differentiation in GBM cells, representing a novel and promising pathway for the advancement of GBM treatment. 10.1111/cpr.70013 http://creativecommons.org/licenses/by/4.0/
title Rapid and Effective Neuronal Conversion of Human Glioblastoma In Vitro and In Vivo Using Potent Small Molecules
topic Cell Proliferation
url https://onlinelibrary.wiley.com/doi/10.1111/cpr.70013